Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04033081 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04033081 · ClinicalTrials.gov record · last posted 2026-03-23

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

StatusActive, Not Recruiting
PhasePhase 4
Started2020-04-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This patient study will determine the safety and toxicity of a permanently implantable brachytherapy source - CivaSheet® - which is designed to deliver a therapeutic dose of low dose rate (LDR) radiation with polymer encased Palladium-103. CivaSheet will be implanted in sarcoma patients with disease presenting in the retroperitoneum, abdomen, pelvis and trunk.

Amendment record 6 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 6 times since 2019-07-23; most recent amendment 2026-03-20. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-04-02
Status change Recruiting→Active, Not Recruitingv5
2020-07-17
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT04033081
Lead Sponsor CivaTech Oncology
Conditions Sarcoma
Enrollment 100 participants
Start Date 2020-04-30
Primary Completion 2027-01 (estimated)
Study Completion 2030-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-23